Position in XGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,650
New position
Shares Held
1,000
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 57 holders
Holding Since
Jun 2026
1 quarter on record
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $12,586,470 across 14 Diagnostics & Research names. XGN ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
24,504 | $4,667,521 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
6,201 | $3,264,454 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
5,365 | $2,689,796 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
7,132 | $1,378,045 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
699 | $158,526 | |
| 6 | LH |
Labcorp Holdings Inc.
|
549 | $153,720 | |
| 7 | DGX |
Quest Diagnostics Inc
|
637 | $135,012 | |
| 8 | A |
Agilent Technologies, Inc.
|
334 | $44,365 |
All Filings in XGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,650 | 1,000 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||